Nikolaeva L, Galabov A S
Department of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia.
Acta Virol. 1999 Oct;43(5):303-11.
To assess the possible interactions among picornavirus replication inhibitors, inhibitory effects of dual combinations of enviroxime, disoxaril, arildone, S-7, guanidine, PTU-23, and HBB on poliovirus type 1 (Mahoney) replication in FL cells were tested. Beforehand, the 50% inhibitory concentration (IC50) in the plaque inhibition test was been determined for each individual compound, i.e. enviroxime-0.2 micromol/l, disoxaril-0.3 micromol/l, arildone-2.7 micromol/l, (S-7)-100 micromol/l, guanidine-200 micromol/l, (PTU-23)-200 micromol/l, and HBB-300 micromol/l. Each of the dual combinations, in which enviroxime or HBB was one of the partners, showed synergistic or additive effects. Combining disoxaril with enviroxime, HBB or PTU-23 resulted in synergism, while combining it with guanidine, S-7 or arildone led to antagonism. Arildone showed additive or synergistic effects when combined with enviroxime, HBB and PTU-23, and antagonistic ones when combined with disoxaril, S-7 or guanidine. All dual combinations of PTU-23 were synergistic with the exception of the pair of PTU-23 + guanidine that was antagonistic. Guanidine had additive to synergistic interactions with HBB or enviroxime but antagonistic ones with disoxaril, arildone and PTU-23. Guanidine or PTU-23 when combined with S-7 showed an unusual effect - synergistic one with an antagonistic zone. The combinations of S-7 with enviroxime or HBB were synergistic but those with disoxaril or arildone were antagonistic. Research on interactions of picornavirus replication inhibitors could possibly contribute to the development of efficient chemotherapy of infectious diseases caused by picornaviruses as well as to the better understanding of the mode of action of those inhibitors.
为评估微小核糖核酸病毒复制抑制剂之间可能存在的相互作用,测试了恩韦肟、双异丙氧乙酰胺、阿立酮、S-7、胍、PTU-23和HBB的二元组合对脊髓灰质炎病毒1型(Mahoney株)在FL细胞中复制的抑制作用。事先,已通过蚀斑抑制试验确定了每种单独化合物的50%抑制浓度(IC50),即恩韦肟-0.2微摩尔/升、双异丙氧乙酰胺-0.3微摩尔/升、阿立酮-2.7微摩尔/升、(S-7)-100微摩尔/升、胍-200微摩尔/升、(PTU-23)-200微摩尔/升和HBB-300微摩尔/升。以恩韦肟或HBB作为其中一种成分的每种二元组合均显示出协同或相加作用。双异丙氧乙酰胺与恩韦肟、HBB或PTU-23组合产生协同作用,而与胍、S-7或阿立酮组合则导致拮抗作用。阿立酮与恩韦肟、HBB和PTU-23组合时显示相加或协同作用,与双异丙氧乙酰胺、S-7或胍组合时则显示拮抗作用。除了PTU-23与胍的组合呈拮抗作用外,PTU-23的所有二元组合均具有协同作用。胍与HBB或恩韦肟具有相加至协同的相互作用,但与双异丙氧乙酰胺、阿立酮和PTU-23具有拮抗作用。胍或PTU-23与S-7组合时显示出一种不同寻常的效应——有拮抗区的协同效应。S-7与恩韦肟或HBB的组合具有协同作用,但与双异丙氧乙酰胺或阿立酮的组合具有拮抗作用。对微小核糖核酸病毒复制抑制剂相互作用的研究可能有助于开发针对由微小核糖核酸病毒引起的传染病的有效化疗方法,以及更好地理解这些抑制剂的作用方式。